Philips launches IntelliSpace Radiation Oncology to accelerate time from patient referral to the start of treatment

NEXT STORY
Orion Group Interim Report January-March 2019
PREV STORY
LIDDS invited to speak at Formulation and Drug Delivery Congress in London
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

PositiveID’s Chief Science Officer Co-Authors Report on Need for Department of Homeland Security’s National Biosurveillance Integration Center

DELRAY BEACH, Fla., Feb. 12, 2018 (GLOBE NEWSWIRE) -- PositiveID Corporation (“PositiveID” or “Company”) ...

author_avatar
NASDAQ Market News

Novartis reports late-breaking data from Phase III COMBI-i trial of spartalizumab (PDR001) with Tafinlar® and Mekinist® in advanced melanoma

author_avatar
NASDAQ Market News

Cue Biopharma Reports Fourth Quarter and Full Year 2019 Financial Results and Recent Business Highlights

author_avatar
NASDAQ Market News